The/DT
carboxyl-terminal/JJ
cytoplasmic/JJ
domain/NN
of/IN
CD36/NN
is/VBZ
required/VBN
for/IN
oxidized/VBN
low-density/JJ
lipoprotein/NN
modulation/NN
of/IN
NF-kappaB/NN
activity/NN
by/IN
tumor/NN
necrosis/NN
factor-alpha/NN
./.

The/DT
binding/NN
of/IN
oxidized/VBN
low-density/JJ
lipoprotein/NN
(/(
Ox/NN
LDL/NN
)/)
by/IN
monocyte-macrophages/NNS
causes/VBZ
pleiotropic/JJ
effects/NNS
,/,
including/VBG
changes/NNS
in/IN
gene/NN
expression/NN
,/,
and/CC
is/VBZ
thought/VBN
to/TO
represent/VB
an/DT
early/JJ
event/NN
in/IN
atherogenesis/NN
./.
=====
The/DT
integral/JJ
membrane/NN
glycoprotein/NN
CD36/NN
appears/VBZ
to/TO
play/VB
a/DT
physiological/JJ
role/NN
in/IN
binding/NN
and/CC
uptake/NN
of/IN
Ox/NN
LDL/NN
by/IN
monocyte-macrophages/NNS
,/,
although/IN
the/DT
molecular/JJ
events/NNS
associated/VBN
with/IN
CD36-Ox/NN
LDL/NN
interaction/NN
are/VBP
unknown/JJ
./.
=====
To/TO
approach/VB
this/DT
issue/NN
,/,
we/PRP
used/VBD
CD36/NN
transfected/JJ
Chinese/JJ
hampster/NN
ovary/NN
(/(
CHO/NN
)/)
cells/NNS
,/,
exposed/VBD
them/PRP
to/TO
Ox/NN
LDL/NN
,/,
and/CC
determined/VBD
changes/NNS
in/IN
the/DT
activity/NN
of/IN
the/DT
transcription/NN
factor/NN
NF-kappaB/NN
./.
=====
We/PRP
report/VBP
here/RB
that/IN
Ox/NN
LDL/NN
enhanced/VBD
DNA/NN
binding/NN
activity/NN
of/IN
nuclear/JJ
extracts/NNS
to/TO
an/DT
NF-kappaB/NN
sequence/NN
following/VBG
activation/NN
of/IN
CD36-producing/JJ
CHO/NN
cells/NNS
with/IN
the/DT
proinflammatory/JJ
cytokine/NN
tumor/NN
necrosis/NN
factor-alpha/NN
(/(
TNF-alpha/NN
)/)
./.
=====
This/DT
enhanced/VBN
DNA/NN
binding/NN
activity/NN
was/VBD
inhibited/VBN
by/IN
coincubation/NN
of/IN
CD36/NN
transfected/VBN
cells/NNS
with/IN
the/DT
human/JJ
CD36-specific/JJ
antibody/NN
OKM5/NN
./.
=====
We/PRP
also/RB
determined/VBD
that/IN
activation/NN
of/IN
NF-kappaB/NN
DNA/NN
binding/NN
activity/NN
required/VBD
an/DT
intact/JJ
carboxyl-terminal/JJ
cytoplasmic/JJ
segment/NN
on/IN
CD36/NN
./.
=====
Our/PRP$
results/NNS
support/VBP
the/DT
idea/NN
that/IN
human/JJ
CD36/NN
mediates/VBZ
signal/NN
transduction/NN
events/NNS
in/IN
response/NN
to/TO
Ox/NN
LDL/NN
./.